
News|Articles|September 1, 2011
Formulary Digital Edition September 2011
Management of chronic obstructive pulmonary disease: An emphasis on recently approved medications and products in the pipeline; Focus On Boceprevir: A new oral protease inhibitor for the treatment of chronic hepatitis C
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
2
Zepbound linked to lower healthcare costs in older adults with obesity
3
FDA approves brepocitinib for rare skin disease
4
Employer health care costs projected to rise 9.5% in 2027, report finds
5













